“The partnership between SPI Pharma, Inc and ingredientpharm, supports SPI’s strategy of adding high performance products to our portfolio, and combined with our formulation expertise, further enhances our solution offering to customers.” said Scott Thomson, CEO of SPI Pharma.
WILMINGTON, Del. (PRWEB) March 08, 2023
SPI Pharma, Inc. (SPI), a global leader in providing specialized solutions to the pharmaceutical industry, announces that it has received sole distribution rights for CELLETS® MCC pellets and TAP® tartaric acid pellets, from ingredientpharm. SPI also received the sole distribution rights to directly compressible Ibuprofen DC100. This agreement includes sole distribution rights for North America, Latin America, New Zealand, and Australia. SPI plans to distribute the MCC pellets as ACTILLETS™ MCC pellets in these regions.
Microcrystalline cellulose and tartaric acid pellets are used to create modified release drugs and multi-unit particulate systems (MUPS) when used as starter cores for drug layering and coating. ACTILLETS™ MCC pellets have low friability, high sphericity, and smooth surfaces for consistent coating. TAP® tartaric acid pellets can be used to improve the solubility of weakly basic pharmaceutical actives. Ibuprofen DC100 is a 100% active granule without addition of further excipients enabling simpler, more cost-effective Ibuprofen formulations.
SPI Pharma is excited to expand its portfolio of pharmaceutical excipients and API’s with the addition of these products. “This partnership supports SPI’s strategy of adding high performance products to our portfolio, and combined with our formulation expertise, further enhances our solution offering to customers.” said Scott Thomson, CEO of SPI Pharma.
About SPI Pharma, Inc.
SPI Pharma, headquartered in Wilmington, Delaware, USA, provides innovative solutions to global pharmaceutical and nutritional customers. Product lines include Antacid Actives, Excipients, Drug Delivery Systems, Taste-Masking, and Vaccine Adjuvants. SPI Pharma specializes in drug development services, having participated in over 60 commercially launched and marketed drugs globally. With its sites in the United States, France, and India, the company solves the most challenging formulation problems –– efficiently, cost-effectively, and with a focus on service.
ingredientpharm is a brand name of ADD Advanced Drug Delivery Technologies Ltd, Pratteln, Switzerland. ingredientpharm provides innovative drug carriers by changing the physical properties of existing excipients. We offer our expertise and technology to enhance the performance of APIs – mainly in the field of taste masking but also for easier processing. We can support our customers with tailor-made developments.